These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35099501)

  • 1. Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial.
    Woloshin S; Dewitt B; Krishnamurti T; Fischhoff B
    JAMA Intern Med; 2022 Mar; 182(3):332-341. PubMed ID: 35099501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the Workplace.
    Papenburg J; Campbell JR; Caya C; Dion C; Corsini R; Cheng MP; Menzies D; Yansouni CP
    JAMA Netw Open; 2022 May; 5(5):e2210559. PubMed ID: 35522284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the role of COVID-19 testing availability on intention to isolate: A Randomized hypothetical scenario.
    Zhang JC; Christensen KL; Leuchter RK; Vangala S; Han M; Croymans DM
    PLoS One; 2022; 17(2):e0262659. PubMed ID: 35108307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. At-home COVID-19 Test Instructions Frequently Misinterpreted.
    Slomski A
    JAMA; 2022 Apr; 327(13):1218. PubMed ID: 35380596
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Young BC; Eyre DW; Kendrick S; White C; Smith S; Beveridge G; Nonnenmacher T; Ichofu F; Hillier J; Oakley S; Diamond I; Rourke E; Dawe F; Day I; Davies L; Staite P; Lacey A; McCrae J; Jones F; Kelly J; Bankiewicz U; Tunkel S; Ovens R; Chapman D; Bhalla V; Marks P; Hicks N; Fowler T; Hopkins S; Yardley L; Peto TEA
    Lancet; 2021 Oct; 398(10307):1217-1229. PubMed ID: 34534517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of COVIDTests.gov At-Home Test Kits Among Adults in a National Household Probability Sample - United States, 2022.
    Luisi N; Sullivan PS; Sanchez T; Bradley H; Fahimi M; Shioda K; Nelson KN; Lopman BA; Siegler AJ
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(16):445-449. PubMed ID: 37079516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes - 17 States, June-October 2020.
    Atherstone C; Peterson ML; Malone M; Honein MA; MacNeil A; O'Neal CS; Paul S; Harmon KG; Goerl K; Wolfe CR; Casani J; Barrios LC;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(1):7-11. PubMed ID: 33417591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of At-Home COVID-19 Tests - United States, August 23, 2021-March 12, 2022.
    Rader B; Gertz A; Iuliano AD; Gilmer M; Wronski L; Astley CM; Sewalk K; Varrelman TJ; Cohen J; Parikh R; Reese HE; Reed C; Brownstein JS
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):489-494. PubMed ID: 35358168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 patients and contacted person awareness about home quarantine instructions.
    Elgendy MO; Abd Elmawla MN; Abdel Hamied AM; El Gendy SO; Abdelrahim MEA
    Int J Clin Pract; 2021 Apr; 75(4):e13810. PubMed ID: 33128825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four COVID-19 screening strategies to facilitate early case identification within the homeless shelter population: A structured summary of a study protocol for a randomised controlled trial.
    O'Shea T; Mbuagbaw L; Mokashi V; Bulir D; Gilchrist J; Smieja N; Chong S; Marttala S; Vera V; Cvetkovic A; Smieja M
    Trials; 2020 Nov; 21(1):941. PubMed ID: 33225995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.